MedTrace Logo

Zonisamide vs. Placebo in the Treatment of Alcohol Dependence

NCT00595556 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-10-15

Study results available
· View outcomes & findings →

Summary

This is a pilot study designed to examine the potential efficacy and tolerability of zonisamide compared to placebo for the treatment of alcohol dependence.

Conditions

  • Alcoholism
  • Alcohol Abuse
  • Alcohol Dependence

Interventions

DRUG

zonisamide

flexible dosages of 100-500mg/day

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • UConn Health

    lead OTHER

Principal Investigators

  • Albert J. Arias, MD · UConn Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00595556 on ClinicalTrials.gov